Constitutional rearrangement of the architectural factor HMGA2: A novel human phenotype including overgrowth and lipomas

American Journal of Human Genetics

Volumn 76, Issue 2, 2005, Pages 340-348

  Ligon, Azra H ^a,c   Moore, Steven D P ^a,c   Parisi, Melissa A ^d   Mealiffe, Matthew E ^d,e   Harris, David J ^b,c   Ferguson, Heather L ^a   Quade, Bradley J ^a,c   Morton, Cynthia C ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; LIPID; TERBUTALINE;

ANAMNESIS; ARTICLE; BONE DEVELOPMENT; CASE REPORT; CEREBELLUM TUMOR; CHROMOSOME 12; CLINICAL FEATURE; CRANIOFACIAL MALFORMATION; DENTITION; ENCHONDRAL OSSIFICATION; GENE MAPPING; GENETIC ANALYSIS; GROWTH DISORDER; GROWTH REGULATION; HUMAN; LIPOGENESIS; LIPOMA; MALE; MESENCHYME; PERICENTRIC CHROMOSOME INVERSION; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; TRANSGENIC MOUSE;

MURINAE; MUS MUSCULUS;

EID: 12344293481     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/427565     Document Type: Article

References (37)

1. Anand A, Chada K (2000) In vivo modulation of Hmgic reduces obesity. Nat Genet 24:377-380
2. Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C, Bauters F, Lai JL, Kerckaert JP (2004) Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 39:82-87
3. Arlotta P, Tai AK-F, Manfioletti G, Clifford C, Jay G, Ono SJ (2000) Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem 275:14394-14400
4. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K (1995) Disruption of the architectural factor HMGIC: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65
5. Ashar HR, Tkachenko A, Shah P, Chada K (2003) HMGA2 is expressed in an allele-specific manner in human lipomas. Cancer Genet Cytogenet 143:160-168
6. Battista S, Fidanza V, Fedele M, Klein-Szanto JP, Outwater E, Brunner H, Santoro M, Croce CM, Fusco A (1999) The expression of a truncated HMGIC gene induces gigantism associated with lipomatosis. Cancer Res 59:4793-4797
7. Broberg K, Hoglund M, Limon J, Lindstrand A, Toksvik-Larsen S, Mandahl N, Mertens F (1999) Rearrangement of the neoplasia-associated gene HMGIC in synovia from patients with osteoarthritis. Genes Chromosomes Cancer 24:278-282
8. Broberg K, Tallini G, Hoglund M, Lindstrand A, Toksvig-Larsen S, Mertens F (2001) The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia. Mod Pathol 14:311-317
9. Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnetizke S (1993) Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65:27-31
10. Dahlen A, Mertens F, Rydholm A, Brosjo O, Wejde J, Mandahl N, Panagopoulos I (2003) Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16:1132-1140
11. de Kok YJ, Vossenaar ER, Cremers CW, Dahl N, Laporte J, Hu LJ, Lacombe D, Fischel-Ghodsian N, Friedman RA, Parnes LS, Thorpe P, Bitner-Glindzicz M, Pander HJ, Heilbronner H, Graveline J, den Dunnen JT, Brunner HG, Ropers HH, Cremers FP (1996) Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet 5:1229-1235
12. Dermitzakis ET, Kirkness E, Schwarz S, Birney E, Reymond A, Antonarakis SE (2004) Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. Genome Res 14:852-859
13. Dermitzakis ET, Reymond A, Scamuffa N, Ucla C, Kirkness E, Rossier C, Antonarakis SE (2003) Evolutionary discrimination of mammalian conserved nongenic sequences (CNGs). Science 302:1033-1035
14. Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183-198
15. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A (2001) Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22:1583-1591
16. Fedele M, Berlingiere MT, Scala S, Chiariotti L, Viglietto G, Rippel V, Bullerdiek J, Santoro M, Fusco A (1998) Truncated and chimeric HMGIC genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17:413-418
17. Freyd G, Kim SK, Horvitz HR (1990) Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature 344:876-879
18. Gattas GJF, Quade BJ, Nowak RA, Morton CC (1999) HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 25:316-322
19. Huang W, Chung IU, Kronenberg HM, de Crombrugghe B (2001) The chondrogenic transcription factor SOX9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165
20. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289
21. Kazmierczak B, Bullerdiek J, Pham KH, Bartnitzke S, Wiesner H (1998) Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet Cytogenet 103:175-177
22. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven W, Kayser K, Krieghoff B, Kastendick H, Bartnitzke S, Bullerdiek J (1996) HMGIC rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12:515-521
23. Kwok SC, Liu X, Daskal I (2001) Molecular cloning, expression, localization and gene organization of PTX1, a human nuclear protein that is downregulated in prostate cancer. DNA Cell Biol 20:349-357
24. Ney PA, Andrews NC, Jane SM, Safer B, Purucker NE, Weremowicz S, Morton CC, Goff SC, Orkin SH, Nienhuis AW (1993) Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol Cell Biol 13:5604-5612
25. Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, Birren B, Korniszewski L, Back E, Scherer G (1999) Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 65:111-124
26. Pierantoni GM, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N, Santoro M, Bulrich F, Fusco A (2003) HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 23:363-367
27. Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P, Morton CC (2003) Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 63:1351-1358
28. Reeves R, Beckerbauer L (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519:13-29
29. Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J (1997) HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 26:603-607
30. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
31. Sandros J, Stenman G, Mark J (1990) Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 44:153-167
32. Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V, Bullerdiek J, Fusco A (2000) A 12q13 translocation involving the HMGIC gene in Richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 119:70-73
33. Schoenberg Fejzo M, Yoon S-J, Montgomery KT, Rein MS, Weremowicz S, Krauter KS, Dorman TE, Fletcher JA, Mao J, Moir DT, Kucherlapati RS, Morton CC (1995) Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 26:265-271
34. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM (1995) Recurrent rearrangements in the high mobility group protein gene, HMGIC, in benign mesenchymal tumours. Nat Genet 10:436-443
35. Sreekantaiah C, Leon SLP, Karakousis CP, McGee DL, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PN, Carmona R, Sandberg AA (1991) Cytogenetic profile of 109 lipomas. Cancer Res 51:422-433
36. Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, Chada KK (1997) Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res 57:2276-2280
37. Zhou X, Benson KF, Ashar HR, Chada K (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGIC. Nature 376:771-774